I
IFRX
Inflarx
0.9872
+0.0200+2.07%Opening12:01 04/08 EDT
OPEN/PREV CLOSE0.9999/0.9672
TODAY RANGE0.9705-1.030
VOL117.30K
MARKET CAP71.37M
52 WEEK RANGE0.7113-1.940
AVG VOL (3M)427.10K
% TURNOVER0.16%
TURNOVER--
P/E (TTM)-1.2402
% RANGE6.15%
EPS(TTM)-0.7960
P/E(FORWARD)-1.6887
P/B1.463
BVPS0.6746
DIVIDEND--
P/S1,974.40
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP67.10M
SHARES OUTSTANDING72.29M
NEXT EARNINGS05/05-05/11
FREE FLOAT67.97M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·04/01 12:35
Guggenheim Reaffirms Their Buy Rating on InflaRx (IFRX)
TipRanks·03/30 12:10
InflaRx presents vilobelimab data
Dow Jones·03/20 12:52
InflaRx Is Maintained at Buy by Guggenheim
Dow Jones·03/20 12:52
InflaRx Price Target Cut to $14.00/Share From $22.00 by Guggenheim
Benzinga·03/20 12:43
Guggenheim Maintains Buy on InflaRx, Lowers Price Target to $14
TipRanks·03/20 11:20
InflaRx price target lowered to $14 from $22 at Guggenheim
NASDAQ·03/19 12:45
InflaRx N.V. (IFRX) Reports Q4 Loss, Lags Revenue Estimates
TipRanks·03/19 12:24
InflaRx Shifts Strategy to Izicopan as 2025 Results Extend Cash Runway to 2027
Benzinga·03/19 11:11
Earnings Scheduled For March 19, 2026
Seeking Alpha·03/18 22:00
Here are the major earnings before the open Thursday
Same Industry
Name/Symbol
Change%
Price